Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study
Crossref DOI link: https://doi.org/10.1186/s13075-015-0862-4
Published Online: 2015-11-25
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Závada, Jakub
Uher, Michal
Svobodová, Radka
Olejárová, Marta
Hušáková, Markéta
Ciferská, Hana
Hulejová, Hana
Tomčík, Michal
Šenolt, Ladislav
Vencovský, Jiří
Funding for this research was provided by:
Ministerstvo Zdravotnictví Ceské Republiky (CZ) (NT 13707)
